Ashland Global vs Chemours
Chemours reported revenue of $5.8 billion in fiscal 2025, 3.2 times Ashland Global's $1.8 billion in fiscal 2025. Ashland Global's revenue fell 13.7% in its latest year, and Chemours' grew 0.5%. Free cash flow was $36 million at Ashland Global and $51 million at Chemours. Their fiscal years end in different months (September 30 and December 31), so the periods don't line up exactly.
Side by side
| Ashland Global | Chemours | |
|---|---|---|
| Latest fiscal year | FY2025, Sep 30, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.8B | $5.8B |
| Revenue growth | −13.7% | 0.5% |
| Revenue growth a year, last 5 years | −2.0% | 3.2% |
| Gross margin | 30.1% | 15.5% |
| Operating margin | −42.5% | — |
| Net margin | −46.3% | −6.7% |
| Free cash flow | $36M | $51M |
| Free cash flow margin | 2.0% | 0.9% |
| Return on capital | −17.5% | −0.2% |
| Net debt to EBITDA | — | 10.6x |
| Dividends and buybacks | $176M | $78M |
| Change in diluted share count | −8.0% | 0.0% |
| Last close | $72.32 | $12.87 |
| P/E at the last close | 68.9× | — |
| Insider trades, last 12 months | — | bought $488,650, sold $0 |
| Piotroski F-score | 5 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Ashland GlobalChemours
Operating margin
Percent of revenue
Ashland GlobalChemours
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Ashland GlobalChemours
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ashland Global and Chemours pages.